Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

F Giovinazzo; F Soggiu; JY Jang; E Versteijne; G van Tienhoven; Casper van Eijck; YM Han; SH Choi; CM Kang; M Zalupski; H Ahmad; S Yentz; S Helton; JB Rose; C Takishita; Y Nagakawa; M Abu Hilal

doi:10.3389/fonc.2020.01112

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

F Giovinazzo, F Soggiu, JY Jang, E Versteijne, G van Tienhoven, Casper van Eijck, YM Han, SH Choi, CM Kang, M Zalupski, H Ahmad, S Yentz, S Helton, JB Rose, C Takishita, Y Nagakawa, M Abu Hilal

Surgery

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

7 Downloads (Pure)

Original language	English
Article number	1112
Journal	Frontiers in Oncology
Volume	10
DOIs	https://doi.org/10.3389/fonc.2020.01112
Publication status	Published - 2020

Access to Document

10.3389/fonc.2020.01112

Repub_130481_O-A.pdfFinal published version, 1.47 MB

http://hdl.handle.net/1765/130481

Cite this

Giovinazzo, F., Soggiu, F., Jang, JY., Versteijne, E., van Tienhoven, G., van Eijck, C., Han, YM., Choi, SH., Kang, CM., Zalupski, M., Ahmad, H., Yentz, S., Helton, S., Rose, JB., Takishita, C., Nagakawa, Y., & Abu Hilal, M. (2020). Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data. Frontiers in Oncology, 10, Article 1112. https://doi.org/10.3389/fonc.2020.01112

@article{f6c75e186b534f86abc2fb627065a5f9,

title = "Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data",

author = "F Giovinazzo and F Soggiu and JY Jang and E Versteijne and {van Tienhoven}, G and {van Eijck}, Casper and YM Han and SH Choi and CM Kang and M Zalupski and H Ahmad and S Yentz and S Helton and JB Rose and C Takishita and Y Nagakawa and {Abu Hilal}, M",

year = "2020",

doi = "10.3389/fonc.2020.01112",

language = "English",

volume = "10",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S.A.",

}

Giovinazzo, F, Soggiu, F, Jang, JY, Versteijne, E, van Tienhoven, G, van Eijck, C, Han, YM, Choi, SH, Kang, CM, Zalupski, M, Ahmad, H, Yentz, S, Helton, S, Rose, JB, Takishita, C, Nagakawa, Y & Abu Hilal, M 2020, 'Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data', Frontiers in Oncology, vol. 10, 1112. https://doi.org/10.3389/fonc.2020.01112

TY - JOUR

T1 - Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

AU - Giovinazzo, F

AU - Soggiu, F

AU - Jang, JY

AU - Versteijne, E

AU - van Tienhoven, G

AU - van Eijck, Casper

AU - Han, YM

AU - Choi, SH

AU - Kang, CM

AU - Zalupski, M

AU - Ahmad, H

AU - Yentz, S

AU - Helton, S

AU - Rose, JB

AU - Takishita, C

AU - Nagakawa, Y

AU - Abu Hilal, M

PY - 2020

Y1 - 2020

U2 - 10.3389/fonc.2020.01112

DO - 10.3389/fonc.2020.01112

M3 - Article

SN - 2234-943X

VL - 10

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1112

ER -